Ace the APEA Predictor Test 2026 – Unlock Your Nursing Superpowers!

Alpha fetoprotein (AFP) screening is typically performed during the second trimester of pregnancy, specifically between 15 to 20 weeks of gestation. This timeframe allows for the detection of certain fetal conditions, such as neural tube defects and Down syndrome, as the levels of AFP in the mother’s blood can be indicative of these conditions.

The screening involves measuring the levels of AFP, a protein produced by the fetal liver, which can provide valuable information about the health of the fetus. If the AFP levels are abnormal, additional testing may be recommended to further investigate potential congenital abnormalities.

Performing the test during the specified 15 to 20-week window is optimal because it balances the risks of a false positive or negative result with the gestational age where fetal development can be accurately assessed. Conducting the screening too early might lead to inaccurate readings, whereas testing too late may not yield as useful diagnostic information.